Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Optimer Biotechnology Inc Announces Change of General Manager


Wednesday, 10 Apr 2013 07:29am EDT 

Optimer Biotechnology Inc announced the change of its General Manager from Xu Yougong, who is also the Company's Chief Executive Officer, to Huang Xiumei, the Company's Chief Operating Officer. 

Company Quote

320.0
-2.43 -0.75%
29 Aug 2014